First Intra-Nasal Corona Vaccine to be Launched on Republic Day

now viewing

First Intra-Nasal Corona Vaccine to be Launched on Republic Day

January 21, 2023 Editor In Chief

now playing

Catastrophe: Over 280 mn in 59 countries faced acute hunger in 2023, says FAO

January 21, 2023 Editor In Chief

now playing

Roving Periscope: Worried, the West prepares for Trump’s return to WH!

January 21, 2023 Editor In Chief

now playing

PM Modi’s statements about nation’s resources combat brazen appeasement of Congress

January 21, 2023 Editor In Chief

now playing

What a relief: Britain “observes closely,” and discusses how horses bolted!

January 21, 2023 Editor In Chief

now playing

ACC delivers lifetime highest annualised PAT

January 21, 2023 Editor In Chief

now playing

Dubai rainstorm: “Great lessons learned,” says the UAE; announces $544 mn for repairs

January 21, 2023 Editor In Chief

now playing

Kotak Mahindra Bank Barred from Taking New Online Customers, Issuing New Credit Cards

January 21, 2023 Editor In Chief

now playing

BJP Expels Bikaner Minority Cell President for Criticising Modi on Muslim Comments

January 21, 2023 Editor In Chief

now playing

Banswara: Congress Campaigning Against its Own Candidate

January 21, 2023 Editor In Chief

now playing

Judgement Reserved on Total Verification of VVPAT Slips, but SC Satisfied on ECI Clarifications

January 21, 2023 Editor In Chief

Social Share

NEW DELHI, Jan 21: Home-grown vaccine maker Bharat Biotech will launch the country’s first intra-nasal COVID-19 vaccine iNCOVACC on January 26, the company’s chairman and managing director Krishna Ella said on Saturday.

Interacting with students at the India International Science Festival in Bhopal, Ella also said the home-grown vaccine for the lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month.

“Our nasal vaccine will be officially launched on January 26, on Republic Day,” Ella said, participating in the ‘Face-to-Face with New Frontiers in Science’ segment of the IISF, organised at the Maulana Azad National Institute of Technology (MANIT).

In December, Bharat Biotech had announced that it would sell the intranasal vaccine for ₹ 325 per shot for procurement by the government and ₹ 800 per shot for private vaccination centres.

(Manas Dasgupta)